These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14766201)

  • 1. The monotopic membrane protein human oxidosqualene cyclase is active as monomer.
    Ruf A; Müller F; D'Arcy B; Stihle M; Kusznir E; Handschin C; Morand OH; Thoma R
    Biochem Biophys Res Commun; 2004 Mar; 315(2):247-54. PubMed ID: 14766201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase.
    Thoma R; Schulz-Gasch T; D'Arcy B; Benz J; Aebi J; Dehmlow H; Hennig M; Stihle M; Ruf A
    Nature; 2004 Nov; 432(7013):118-22. PubMed ID: 15525992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of functional human oxidosqualene cyclase in Escherichia coli.
    Kürten C; Uhlén M; Syrén PO
    Protein Expr Purif; 2015 Nov; 115():46-53. PubMed ID: 25962741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification, kinetics, inhibitors and CD for recombinant β-amyrin synthase from Euphorbia tirucalli L and functional analysis of the DCTA motif, which is highly conserved among oxidosqualene cyclases.
    Ito R; Masukawa Y; Hoshino T
    FEBS J; 2013 Mar; 280(5):1267-80. PubMed ID: 23294602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into oxidosqualene cyclizations through homology modeling.
    Schulz-Gasch T; Stahl M
    J Comput Chem; 2003 Apr; 24(6):741-53. PubMed ID: 12666166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear.
    Huff MW; Telford DE
    Trends Pharmacol Sci; 2005 Jul; 26(7):335-40. PubMed ID: 15951028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin.
    Morand OH; Aebi JD; Dehmlow H; Ji YH; Gains N; Lengsfeld H; Himber J
    J Lipid Res; 1997 Feb; 38(2):373-90. PubMed ID: 9162756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbelliferone aminoalkyl derivatives, a new class of squalene-hopene cyclase inhibitors.
    Cravotto G; Balliano G; Tagliapietra S; Palmisano G; Penoni A
    Eur J Med Chem; 2004 Nov; 39(11):917-24. PubMed ID: 15501540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase.
    Lenhart A; Reinert DJ; Aebi JD; Dehmlow H; Morand OH; Schulz GE
    J Med Chem; 2003 May; 46(11):2083-92. PubMed ID: 12747780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase: a chemistry-biology interdisciplinary study of the protein's structure-function-reaction mechanism relationships.
    Wu TK; Chang CH; Liu YT; Wang TT
    Chem Rec; 2008; 8(5):302-25. PubMed ID: 18956480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
    Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
    J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification, tandem mass characterization, and inhibition studies of oxidosqualene-lanosterol cyclase enzyme from bovine liver.
    Wu TK; Huang CY; Ko CY; Chang CH; Chen YJ; Liao HK
    Arch Biochem Biophys; 2004 Jan; 421(1):42-53. PubMed ID: 14678783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors.
    Lange S; Keller M; Müller C; Oliaro-Bosso S; Balliano G; Bracher F
    Eur J Med Chem; 2013 May; 63():758-64. PubMed ID: 23583910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes.
    Shenoy SD; Spencer TA; Mercer-Haines NA; Abdolalipour M; Wurster WL; Runge-Morris M; Kocarek TA
    Mol Pharmacol; 2004 May; 65(5):1302-12. PubMed ID: 15102959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.
    Galli U; Oliaro-Bosso S; Taramino S; Venegoni S; Pastore E; Tron GC; Balliano G; Viola F; Sorba G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):220-4. PubMed ID: 17027267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles.
    Brown GR; Hollinshead DM; Stokes ES; Clarke DS; Eakin MA; Foubister AJ; Glossop SC; Griffiths D; Johnson MC; McTaggart F; Mirrlees DJ; Smith GJ; Wood R
    J Med Chem; 1999 Apr; 42(7):1306-11. PubMed ID: 10197973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of squalene to the pentacarbocyclic hopene.
    Reinert DJ; Balliano G; Schulz GE
    Chem Biol; 2004 Jan; 11(1):121-6. PubMed ID: 15113001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
    Ceruti M; Rocco F; Viola F; Balliano G; Milla P; Arpicco S; Cattel L
    J Med Chem; 1998 Feb; 41(4):540-54. PubMed ID: 9484504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthetic Mechanism of Lanosterol: Cyclization.
    Chen N; Wang S; Smentek L; Hess BA; Wu R
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8693-6. PubMed ID: 26069216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding site for an inhibitor of squalene:hopene cyclase determined using photoaffinity labeling and molecular modeling.
    Dang T; Abe I; Zheng YF; Prestwich GD
    Chem Biol; 1999 Jun; 6(6):333-41. PubMed ID: 10375539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.